AbbVie Inc. (ABBV) vs UnitedHealth Group Incorporated (UNH)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

UnitedHealth Group Incorporated is among the world’s largest private health insurers, providing medical benefits to roughly 51 million members globally as of December 2025, including about 1 million outside the United States. A leading provider of employer-sponsored, self-directed, and government-supported health plans, the company has built substantial scale in the medical insurance market. In addition to its core insurance operations, UnitedHealth’s Optum businesses expand its reach across healthcare services, spanning pharmacy benefits, outpatient care, and analytics for affiliated organizations and third-party clients.